This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Novartis Pharma Ag. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: The Innovations of Andrew Patrick Price
Introduction
Andrew Patrick Price is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of chimeric antigen receptor-expressing cells. His work is crucial in advancing therapeutic strategies for various diseases.
Latest Patents
Andrew holds a patent titled "Methods of Making Chimeric Antigen Receptor-Expressing Cells." This patent represents a significant advancement in the field, showcasing innovative techniques that can enhance the efficacy of cell-based therapies. He has 1 patent to his name, reflecting his commitment to innovation in biotechnology.
Career Highlights
Currently, Andrew is employed at Novartis Pharma AG, a leading global healthcare company. His role at Novartis allows him to work on cutting-edge research and development projects that aim to improve patient outcomes through innovative therapies.
Collaborations
Throughout his career, Andrew has collaborated with talented individuals such as Xu Zhu and Jennifer Brogdon. These collaborations have fostered a dynamic environment for innovation and have contributed to the success of his projects.
Conclusion
Andrew Patrick Price is a distinguished inventor whose work in biotechnology is paving the way for new therapeutic approaches. His contributions, particularly in the area of chimeric antigen receptor technology, are vital for the future of medicine.